Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914316 · ClinicalTrials.gov registry record · NA
Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00914316 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 29 participants.
The verdict
NCT00914316, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate whether supervised treadmill exercise combined with ranolazine 1000 mg twice daily provides an incremental benefit in absolute walking distance over supervised exercise alone in patients with stable claudication. Investigators also seek to determine if the administration of ranolazine provides a sustained benefit after the completion of a supervised exercise regimen. Lastly, investigators wish to determine whether both exercise and ranolazine improves peak oxygen consumption and anaerobic threshold in patients with stable claudication.
Interventions
- DRUG Placebo
- DRUG Ranolazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00914316
The ClinicalTrials.gov registry entry for NCT00914316 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00914316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00914316 about?
NCT00914316 is a clinical study titled "Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities". The goal of this study is to evaluate whether supervised treadmill exercise combined with ranolazine 1000 mg twice daily provides an incremental benefit in absolute walking distance over supervised exercise alone in patients with stable claudication. Investigators also seek to determine if the admin...
What is the current status of trial NCT00914316?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2009-05. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00914316?
The interventions under investigation include: Placebo (DRUG), Ranolazine (DRUG).
Who is sponsoring clinical trial NCT00914316?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.